| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c21057 _d21057 |
||
| 001 | BD-DhNSU-21057 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064843.0 | ||
| 008 | 190403s2000 flua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0748407456 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aQD431 _b.P45 2000 |
| 245 | 0 | 0 |
_aPharmaceutical formulation development of peptides and proteins / _cedited by Sven Frokjaer and Lars Hovgaard |
| 260 |
_aBoca Raton : _bCRC Press, _cc2000. |
||
| 300 |
_axviii, 23 p. : _bill. ; _c25 cm. |
||
| 650 | 0 | _aPeptides | |
| 650 | 4 | _aProteins | |
| 650 | 4 | _aPharmaceutical industry | |
| 700 | 1 | _aFrokjaer, Sven | |
| 700 | 1 | _aHovgaard, Lars | |
| 942 |
_2lcc _cBK |
||